SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

Insights from the NRC’s Annie Caputo

December 16, 2024, 12:00PMNuclear News

In a one-on-one interview with the American Nuclear Society’s chief executive officer/executive director Craig Piercy, Nuclear Regulatory Commission commissioner Annie Caputo shared her...

Gail H. Marcus—ANS member since 1973

November 25, 2024, 7:03AMANS News

I like to say that I ended up at Massachusetts Institute of Technology because of my father. He saw that I seemed intimidated by the prospect of going there, so he dared me, figuring I would...